NADAC acquisition cost data for LUCEMYRA 0.18 MG TABLET. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 27505005036 | $19.78 | 2021-06-23 | Rx |
| 27505005096 | $19.78 | 2021-06-23 | Rx |
| 78670005036 | $19.78 | 2021-06-23 | Rx |
| 78670005096 | $19.78 | 2021-06-23 | Rx |
| 27505005036 | $19.78 | 2021-06-23 | Rx |
| 27505005096 | $19.78 | 2021-06-23 | Rx |
| 78670005036 | $19.78 | 2021-06-23 | Rx |
| 78670005096 | $19.78 | 2021-06-23 | Rx |
| 27505005036 | $19.78 | 2021-06-23 | Rx |
| 27505005096 | $19.78 | 2021-06-23 | Rx |
Generic: Lofexidine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | 1,577 | N/A |
| 2020 | N/A | N/A | 705 | N/A |
| 2021 | $1.2M | 463 | 656 | $21.64 |
| 2022 | $2.5M | 867 | 686 | $22.43 |
| 2023 | $3.1M | 979 | 781 | $24.55 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| North Carolina | $1.3M | 335 | 285 |
| California | $346.3K | 98 | 63 |
| Ohio | $241.6K | 59 | 56 |
| Indiana | $186.5K | 52 | 40 |
| Kentucky | $180.1K | 90 | 77 |
| Tennessee | $111.2K | 40 | 29 |
| Colorado | $84.7K | 28 | 23 |
| Maryland | $84.0K | 34 | 23 |
| Georgia | $82.6K | 26 | 23 |
| New York | $67.8K | 27 | 24 |
| Connecticut | $50.2K | 24 | 17 |
| New Jersey | $38.8K | 17 | 14 |
| Michigan | $38.4K | 22 | 15 |
| Florida | $37.4K | 15 | N/A |
| Texas | $36.8K | 14 | N/A |
| Wisconsin | $32.4K | 13 | 11 |
| Arizona | $29.6K | 13 | N/A |
| Pennsylvania | $24.6K | 13 | 12 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.